Literature DB >> 19369321

Herpes simplex virus glycoprotein B associates with target membranes via its fusion loops.

Brian P Hannah1, Tina M Cairns, Florent C Bender, J Charles Whitbeck, Huan Lou, Roselyn J Eisenberg, Gary H Cohen.   

Abstract

Herpes simplex virus (HSV) glycoproteins gB, gD, and gH/gL are necessary and sufficient for virus entry into cells. Structural features of gB are similar to those of vesicular stomatitis virus G and baculovirus gp64, and together they define the new class III group of fusion proteins. Previously, we used mutagenesis to show that three hydrophobic residues (W174, Y179, and A261) within the putative gB fusion loops are integral to gB function. Here we expanded our analysis, using site-directed mutagenesis of each residue in both gB fusion loops. Mutation of most of the nonpolar or hydrophobic amino acids (W174, F175, G176, Y179, and A261) had severe effects on gB function in cell-cell fusion and null virus complementation assays. Of the six charged amino acids, mutation of H263 or R264 also negatively affected gB function. To further analyze the mutants, we cloned the ectodomains of the W174R, Y179S, H263A, and R264A mutants into a baculovirus expression system and compared them with the wild-type (WT) form, gB730t. As shown previously, gB730t blocks virus entry into cells, suggesting that gB730t competes with virion gB for a cell receptor. All four mutant proteins retained this function, implying that fusion loop activity is separate from gB-receptor binding. However, unlike WT gB730t, the mutant proteins displayed reduced binding to cells and were either impaired or unable to bind naked, cholesterol-enriched liposomes, suggesting that it may be gB-lipid binding that is disrupted by the mutations. Furthermore, monoclonal antibodies with epitopes proximal to the fusion loops abrogated gB-liposome binding. Taken together, our data suggest that gB associates with lipid membranes via a fusion domain of key hydrophobic and hydrophilic residues and that this domain associates with lipid membranes during fusion.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19369321      PMCID: PMC2698560          DOI: 10.1128/JVI.00301-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  56 in total

1.  Antigenic and functional analysis of a neutralization site of HSV-1 glycoprotein D.

Authors:  M I Muggeridge; T T Wu; D C Johnson; J C Glorioso; R J Eisenberg; G H Cohen
Journal:  Virology       Date:  1990-02       Impact factor: 3.616

2.  Linker-insertion nonsense and restriction-site deletion mutations of the gB glycoprotein gene of herpes simplex virus type 1.

Authors:  W Z Cai; S Person; S C Warner; J H Zhou; N A DeLuca
Journal:  J Virol       Date:  1987-03       Impact factor: 5.103

3.  Fine mapping of antigenic site II of herpes simplex virus glycoprotein D.

Authors:  V J Isola; R J Eisenberg; G R Siebert; C J Heilman; W C Wilcox; G H Cohen
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

4.  Membrane fusion activity of the influenza virus hemagglutinin. The low pH-induced conformational change.

Authors:  R W Doms; A Helenius; J White
Journal:  J Biol Chem       Date:  1985-03-10       Impact factor: 5.157

5.  Role of glycoprotein B of herpes simplex virus type 1 in viral entry and cell fusion.

Authors:  W H Cai; B Gu; S Person
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

6.  High-level expression and purification of secreted forms of herpes simplex virus type 1 glycoprotein gD synthesized by baculovirus-infected insect cells.

Authors:  W P Sisk; J D Bradley; R J Leipold; A M Stoltzfus; M Ponce de Leon; M Hilf; C Peng; G H Cohen; R J Eisenberg
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

7.  Identification of functional regions of herpes simplex virus glycoprotein gD by using linker-insertion mutagenesis.

Authors:  H Y Chiang; G H Cohen; R J Eisenberg
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

8.  Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product.

Authors:  G I Evan; G K Lewis; G Ramsay; J M Bishop
Journal:  Mol Cell Biol       Date:  1985-12       Impact factor: 4.272

9.  Structure of a trimeric variant of the Epstein-Barr virus glycoprotein B.

Authors:  Marija Backovic; Richard Longnecker; Theodore S Jardetzky
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-05       Impact factor: 11.205

10.  Sequential isolation of proteoglycan synthesis mutants by using herpes simplex virus as a selective agent: evidence for a proteoglycan-independent virus entry pathway.

Authors:  B W Banfield; Y Leduc; L Esford; K Schubert; F Tufaro
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

View more
  72 in total

1.  Structure-based functional analyses of domains II and III of pseudorabies virus glycoprotein H.

Authors:  Sebastian W Böhm; Elisa Eckroth; Marija Backovic; Barbara G Klupp; Felix A Rey; Thomas C Mettenleiter; Walter Fuchs
Journal:  J Virol       Date:  2014-11-12       Impact factor: 5.103

2.  Autographa californica multiple nucleopolyhedrovirus GP64 protein: roles of histidine residues in triggering membrane fusion and fusion pore expansion.

Authors:  Zhaofei Li; Gary W Blissard
Journal:  J Virol       Date:  2011-09-21       Impact factor: 5.103

3.  Residues within the C-terminal arm of the herpes simplex virus 1 glycoprotein B ectodomain contribute to its refolding during the fusion step of virus entry.

Authors:  Sarah A Connolly; Richard Longnecker
Journal:  J Virol       Date:  2012-04-04       Impact factor: 5.103

4.  Glycoprotein B of herpes simplex virus 2 has more than one intracellular conformation and is altered by low pH.

Authors:  Martin I Muggeridge
Journal:  J Virol       Date:  2012-04-18       Impact factor: 5.103

5.  HSV Recombinant Vectors for Gene Therapy.

Authors:  Roberto Manservigi; Rafaela Argnani; Peggy Marconi
Journal:  Open Virol J       Date:  2010-06-18

6.  Features of a spatially constrained cystine loop in the p10 FAST protein ectodomain define a new class of viral fusion peptides.

Authors:  Christopher Barry; Tim Key; Rami Haddad; Roy Duncan
Journal:  J Biol Chem       Date:  2010-04-02       Impact factor: 5.157

7.  Characterisation of the epitope for a herpes simplex virus glycoprotein B-specific monoclonal antibody with high protective capacity.

Authors:  Martin P Däumer; Beate Schneider; Doris M Giesen; Sheriff Aziz; Rolf Kaiser; Bernd Kupfer; Karl E Schneweis; Jens Schneider-Mergener; Ulrich Reineke; Bertfried Matz; Anna M Eis-Hübinger
Journal:  Med Microbiol Immunol       Date:  2010-10-08       Impact factor: 3.402

8.  Cascade of events governing cell-cell fusion induced by herpes simplex virus glycoproteins gD, gH/gL, and gB.

Authors:  Doina Atanasiu; Wan Ting Saw; Gary H Cohen; Roselyn J Eisenberg
Journal:  J Virol       Date:  2010-09-22       Impact factor: 5.103

9.  Fusion of Epstein-Barr virus with epithelial cells can be triggered by αvβ5 in addition to αvβ6 and αvβ8, and integrin binding triggers a conformational change in glycoproteins gHgL.

Authors:  Liudmila S Chesnokova; Lindsey M Hutt-Fletcher
Journal:  J Virol       Date:  2011-09-28       Impact factor: 5.103

10.  Dual split protein-based fusion assay reveals that mutations to herpes simplex virus (HSV) glycoprotein gB alter the kinetics of cell-cell fusion induced by HSV entry glycoproteins.

Authors:  Doina Atanasiu; Wan Ting Saw; John R Gallagher; Brian P Hannah; Zene Matsuda; J Charles Whitbeck; Gary H Cohen; Roselyn J Eisenberg
Journal:  J Virol       Date:  2013-08-14       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.